Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mier

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
The purification and properties of human T cell growth factorJ W Mier, R C Gallo
Molecular Biology of the Cell|May 1, 1997
Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblastsR A Janssen, J W Mier
International Journal of Immunopathology and Pharmacology|May 17, 2003
Differential effects of hydroxamate inhibitors on PMA and ligand-induced L-Selectin down-modulation: role of membrane proximal and cytoplasmic domainsR R Jasuja, J W Mier
The New England Journal of Medicine|October 8, 1987
LymphokinesC A Dinarello, J W Mier
Current Opinion in Oncology|November 1, 1993
Mechanisms of action and toxicity of immunotherapy with cytokinesJ W Mier, M B Atkins
Annual Review of Medicine|January 1, 1986
InterleukinsC A Dinarello, J W Mier
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1980
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned mediaJ W Mier, R C Gallo
Clinical Immunology Reviews|January 1, 1983
T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatmentD R Parkinson, J W Mier
The Yale Journal of Biology and Medicine|March 1, 1986
Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing?C A Dinarello, P Conti, J W Mier
Immunology Today|September 18, 1997
IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsH Tilg, C A Dinarello, J W Mier
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
The purification and properties of human T cell growth factorJ W Mier, R C Gallo
Molecular Biology of the Cell|May 1, 1997
Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblastsR A Janssen, J W Mier
International Journal of Immunopathology and Pharmacology|May 17, 2003
Differential effects of hydroxamate inhibitors on PMA and ligand-induced L-Selectin down-modulation: role of membrane proximal and cytoplasmic domainsR R Jasuja, J W Mier
The New England Journal of Medicine|October 8, 1987
LymphokinesC A Dinarello, J W Mier
Current Opinion in Oncology|November 1, 1993
Mechanisms of action and toxicity of immunotherapy with cytokinesJ W Mier, M B Atkins
Annual Review of Medicine|January 1, 1986
InterleukinsC A Dinarello, J W Mier
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1980
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned mediaJ W Mier, R C Gallo
Clinical Immunology Reviews|January 1, 1983
T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatmentD R Parkinson, J W Mier
The Yale Journal of Biology and Medicine|March 1, 1986
Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing?C A Dinarello, P Conti, J W Mier
Immunology Today|September 18, 1997
IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsH Tilg, C A Dinarello, J W Mier
Pageof 9